Antigen-specific B cell tolerance in the gut-associated lymphoid tissue (GALT)

NIH RePORTER · NIH · R01 · $487,500 · view on reporter.nih.gov ↗

Abstract

 DESCRIPTION (provided by applicant): Pathogens and dietary factors are transported across the gut epithelium. This poses a challenge of discriminating innocuous versus harmful antigens by innate and adaptive immune mechanisms. How B cells contribute to these processes is poorly understood. Moreover, recent studies indicate that B cells also undergo BCR diversification in the GALT, indicating that tolerance mechanisms need to be in place to eliminate newly arising autoreactive B cells. In the proposed work, we will use the conditional expression of a neo-self antigen to investigate B cell tolerance to epithelia-associated antigens in the GALT. This mouse model mimics the situation in some ulcerative colitis patients who produce auto-antibodies to antigens on epithelial cells of the colon. Proof-of-concept for the proposed studies is provided by our preliminary findings, showing that antigens expressed on the gut epithelia can efficiently eliminate self-reactive B cells. Here we will determine how and where these negative selection events take place, and how these processes are affected by a breach in the gut epithelial barrier as it relates to infection and inflammatory bowel disease.

Key facts

NIH application ID
9828744
Project number
5R01AI122344-05
Recipient
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Principal Investigator
John R Apgar
Activity code
R01
Funding institute
NIH
Fiscal year
2020
Award amount
$487,500
Award type
5
Project period
2015-12-01 → 2020-11-30